Rich Goldberg, M.D., director of the WVU Cancer Institute and Laurence S. and Jean J. DeLynn chair of Oncology, will step down from those positions and transition toward retirement once an interim is named or at the end of the calendar year.
The recruitment process for a successor will begin in the next several weeks and take place in conjunction with an executive search firm.
Dr. Goldberg’s 35-year academic career encompassed caring for thousands of patients, educating trainees and physicians from around the world, conducting research, and managing the Cancer Institute.
Following his retirement, he plans to continue to play a supportive role in mentoring faculty and serving as a resource to the Cancer Institute’s leadership. He and his wife, Lynda, expect to continue to reside in Morgantown.
A formal celebration of Goldberg’s accomplishments and services will be scheduled at a later date and communicated through internal news channels.
"What is Implicit Bias?" — the first of a five-session sequence called Higher Level — will give an overview of implicit bias and demonstrate how even those with the best of intentions can allow inherent assumptions to cloud their judgement.
WVU Pharmacy Associate Professor named Associate Editor of Journal of the American Pharmacists Association
Dr. Kimberly Kelly, an Associate Professor in the School of Pharmacy, Pharmaceutical Systems & Policy and a member of the WVU Cancer Institute Research Program, has been named an Associate Editor of the Journal of the American Pharmacists Association.
Applications due March 2 for Summer Undergraduate Research Program